Healthcare | October 10, 2024
WHO declares India has eliminated Trachoma as a public health problem in 2024
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
DKSH has entered into an exclusive partnership with R-Biomeds to bring the necessary medication to patients in Cambodia
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
Expansion includes a new 5-story, 136k sq. ft. multipurpose building in Sejong
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Subscribe To Our Newsletter & Stay Updated
